Drug intelligence / Profile preview

Colipex

Development stage
Unknown
Lead developer
Harmonium Pharma
Modality
Small Molecules, Recombinant Proteins and Enzymes, Peptides
Administration
Topical
01

Overview

Colipex (also known as Elastargene 3C) is a topical dermocosmetic body cream developed by Harmonium Pharma specifically to prevent and treat lipodystrophy (lipoatrophy and lipohypertrophy) and skin imperfections (such as white scars) at insulin injection or infusion set sites in patients with diabetes. The cream is formulated with a proprietary combination of active ingredients called 3C-Elastargene, which includes hydrolyzed elastin, arnica extract, hydrolyzed collagen, caffeine, and L-carnitine. These components work synergistically to improve skin elasticity, support dermal regeneration, stimulate microcirculation, and promote lipolysis. Clinical studies in children and adolescents with type 1 diabetes using insulin pump therapy have shown that regular application of Colipex not only improves skin scars but also significantly improves glycated hemoglobin (HbA1c) levels, likely by enhancing subcutaneous insulin absorption.

Brand names
Colipex
Other names
3C-ElastargeneElastargene 3CElastargene3CElastargene-3C

Beyond the preview

Go deeper on Colipex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colipex.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call